catc-ex993

On April 17, 2019, Cambridge Bancorp (NASDAQ: CATC) (“Cambridge”), completed its previously announced acquisition of Optima Bank & Trust Company (“Optima”), pursuant to an Agreement and Plan of Merger, dated as of December 5, 2018 (the “Merger Agreement”), by and between Cambridge, Cambridge Trust Company and Optima. Under the terms of the Merger Agreement, Optima merged with and into Cambridge Trust Company (the “Merger”), with Cambridge Trust Company being the surviving entity. As a result of the Merger, each share of Optima common stock was exchanged for either (i) 0.3468 shares of Cambridge common stock, (ii) $32.00 in cash, or (iii) a combination of the two, subject to customary pro ration procedures, which resulted in an aggregated stock / cash consideration mix of 95 percent / 5 percent.

The following unaudited pro forma combined consolidated financial statements have been prepared in accordance with Article 11 of Regulation S-X and combines the historical consolidated financial position and results of operations of Cambridge and its subsidiaries and Optima as an acquisition by Cambridge of Optima using the acquisition method of accounting and giving effect to the related pro forma adjustments described in the accompanying notes. Under the acquisition method of accounting, the assets and liabilities of Optima were recorded by Cambridge at their respective fair values as of the date the Merger was completed. Certain reclassifications were made to Optima’s historical financial information to conform to Cambridge’s presentation of financial information. All significant pro forma adjustments and underlying assumptions are described in the accompanying notes. The unaudited pro forma combined consolidated financial statements give effect to the Merger as if it occurred on January 1, 2018. The unaudited pro forma combined financial statements should be read in conjunction with: Cambridge’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2018, which were included in Cambridge’s Annual Report on Form 10-K for the year ended December 31, 2018, and Cambridge’s unaudited financial statements and the related notes thereto as of and for the six months ended June 30, 2019, which were included in Cambridge’s Quarterly Report on Form 10-Q for the six months ended June 30, 2019, which were filed with the U.S. Securities and Exchange Commission on March 18, 2019, and August 8, 2019, respectively and Optima’s audited financial statements as of and for the year ended December 31, 2018 and 2017 and Optima’s unaudited condensed financial statements as of and for the three months ended March 31, 2019, which are being filed as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K, respectively.

The unaudited pro forma combined condensed financial statements are presented for illustrative purposes only, do not indicate the actual financial results of the combined company had the Merger occurred on January 1, 2018 at the beginning of each period presented, nor are they indicative of Cambridge’s future financial position or financial results.

The unaudited pro forma shareholders’ equity and net income are qualified by the statements set forth under this caption and should not be considered indicative of the market value of Cambridge common stock or the actual or future results of operations of Cambridge for any period. Actual results may be materially different than the pro forma information presented.

	For the Six Months Ended June 30, 2019
	Cambridge Bancorp			Optima Bank
	Historical			Historical (through April 17, 2019)			Adjustments				Pro Forma
	(dollars in thousands, except share data)

Interest and dividend income
Interest on taxable loans	$	37,639		$	6,050		$	591		⁽¹⁾	$	44,280
Interest on tax-exempt loans		213			30			—				243
Interest on taxable investment securities		4,096			155			—				4,251
Interest on tax-exempt investment securities		1,146			—			—				1,146
Dividends on FHLB of Boston stock		157			18			—				175
Interest on overnight investments		337			196			—				533
Total interest and dividend income		43,588			6,449			591				50,628
Interest expense
Interest on deposits		6,880			1,941			63		⁽²⁾		8,884
Interest on borrowed funds		671			195			—				866
Total interest expense		7,551			2,136			63				9,750
Net interest and dividend income		36,037			4,313			528				40,878
Provision for Loan Losses		503			70			—				573
Net interest and dividend income after provision for loan losses		35,534			4,243			528				40,305
Noninterest income
Wealth management revenue		12,543			—			—				12,543
Deposit account fees		1,581			69			—				1,650
ATM/Debit card income		655			99			—				754
Bank owned life insurance income		289			36			—				325
Gain (loss) on disposition of investment securities		(81	)		—			—				(81	)
Gain on loans held for sale		31			47			—				78
Loan related derivative income		441			—			—				441
Other income		643			53			—				696
Total noninterest income		16,102			304			—				16,406
Noninterest expense
Salaries and employee benefits		22,286			2,238			—				24,524
Occupancy and equipment		5,021			678			18		⁽³⁾		5,717
Data processing		2,880			216			—				3,096
Professional services		1,567			414			—				1,981
Marketing		912			94			—				1,006
FDIC Insurance		278			4			—				282
Merger expenses		3,541			3,381			(6,922	)	⁽⁴⁾		—
Other expenses		1,401			195			120		⁽⁵⁾		1,716
Total noninterest expense		37,886			7,220			(6,784	)			38,322
Income before income taxes		13,750			(2,673	)		7,312				18,389
Income tax expense (benefit)		3,280			(570	)		1,755		⁽⁶⁾		4,465
Net income	$	10,470			(2,103	)		5,557			$	13,924
Share data:
Weighted average number of shares outstanding, basic		4,379,141			2,192,588			—		⁽⁷⁾		4,802,407
Weighted average number of shares outstanding, diluted		4,412,239			2,325,417			—		⁽⁷⁾		4,835,505
Basic earnings per share	$	2.37		$	(0.96	)					$	2.90
Diluted earnings per share	$	2.35		$	(0.90	)					$	2.88

Footnotes to Unaudited Pro Forma Condensed Consolidated Statements of Income for the Six Months Ended June 30, 2019:

		For the Year Ended December 31, 2018
		Cambridge Bancorp		Optima Bank
		Historical		Historical		Adjustments				Pro Forma
	(dollars in thousands, except share data)
Interest and dividend income
Interest on taxable loans		$	57,941	$	19,604	$	2,038		⁽¹⁾	$	79,583
Interest on tax-exempt loans			371		30		—				401
Interest on taxable investment securities			7,457		580		—				8,037
Interest on tax-exempt investment securities			2,404		15		—				2,419
Dividends on FHLB of Boston stock			287		56		—				343
Interest on overnight investments			595		263		—				858
Total interest and dividend income			69,055		20,548		2,038				91,641
Interest expense
Interest on deposits			5,023		5,949	$	253		⁽²⁾		11,225
Interest on borrowed funds			444		3		—				447
Total interest expense			5,467		5,952		253				11,672
Net interest and dividend income			63,588		14,596		1,785				79,969
Provision for Loan Losses			1,502		246		—				1,748
Net interest and dividend income after provision for loan losses			62,086		14,350		1,785				78,221
Noninterest income
Wealth management revenue			25,191		—		—				25,191
Deposit account fees			3,071		245		—				3,316
ATM/Debit card income			1,180		344		—				1,524
Bank owned life insurance income			526		153		—				679
Gain (loss) on disposition of investment securities			2		22		—				24
Gain on loans held for sale			99		206		—				305
Loan related derivative income			1,651		—		—				1,651
Other income			1,269		335		—				1,604
Total noninterest income			32,989		1,305		—				34,294
Noninterest expense
Salaries and employee benefits			41,212		7,104		—				48,316
Occupancy and equipment			9,072		2,185		54		⁽³⁾		11,311
Data processing			5,177		552		—				5,729
Professional services			3,258		959		—				4,217
Marketing			2,229		305		—				2,534
FDIC Insurance			574		495		—				1,069
Merger expenses			201		—		(201	)	⁽⁴⁾		—
Other expenses			2,264		477		360		⁽⁵⁾		3,101
Total noninterest expense			63,987		12,077		213				76,277
Income before income taxes			31,088		3,578		1,572				36,238
Income tax expense			7,207		1,002		377		⁽⁶⁾		8,586
Net income		$	23,881		2,576		1,195			$	27,652
Share data:
Weighted average number of shares outstanding, basic			4,061,529		2,069,880				⁽⁷⁾		4,784,275
Weighted average number of shares outstanding, diluted			4,098,633		2,331,569				⁽⁷⁾		4,821,379
Basic earnings per share		$	5.82	$	1.24					$	5.78
Diluted earnings per share		$	5.77	$	1.10					$	5.74

Footnotes to Unaudited Pro Forma Condensed Consolidated Statements of Income for the Year Ended December 31, 2018:

The unaudited pro forma combined condensed consolidated financial information and notes have been prepared to illustrate the effects of the Merger involving Cambridge and Optima using the acquisition method of accounting, with Cambridge treated as the acquirer, as if the Merger had been consummated January 1, 2018. The unaudited pro forma combined condensed consolidated financial information is presented for illustrative purposes only and does not necessarily indicate the financial results of the combined companies had the companies actually been combined at the beginning of each period presented, nor does it necessarily indicate the results of operations in future periods of the combined entity. Under the acquisition method of accounting, the assets and liabilities of Optima, as of the effective date of the Merger, were recorded by Cambridge at their respective fair values and the excess of the Merger consideration over the fair value of the net assets was allocated to goodwill and other intangible assets.

Certain statements herein may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements about Cambridge and its industry involve substantial risks and uncertainties. Statements other than statements of current or historical fact, including statements regarding Cambridge’s future financial condition, results of operations, business plans, liquidity, cash flows, projected costs, and the impact of any laws or regulations applicable to Cambridge, are forward-looking statements. Words such as “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “intends,” “plans,” “projects,” “may,” “will,” “should,” and other similar expressions are intended to identify these forward-looking statements. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. Such factors include, but are not limited to, the following: economic conditions being less favorable than expected, disruptions to the credit and financial markets, weakness in the real estate market, legislative, regulatory or accounting changes that adversely affect Cambridge’s business and/or competitive position, the Dodd-Frank Act’s consumer protection regulations, disruptions in Cambridge’s ability to access the capital markets, changes to accounting standards and other factors that are described in Cambridge’s filings with the U.S. Securities and Exchange Commission, including Cambridge’s Annual Report on Form 10-K for the year end December 31, 2018, which Cambridge filed on March 18, 2019. Cambridge does not undertake, and specifically disclaims any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements. You are cautioned not to place undue reliance on these forward-looking statements.